Literature DB >> 16049063

NF-kappaB in tracheal lavage fluid from intubated premature infants: association with inflammation, oxygen, and outcome.

A Bourbia1, M A Cruz, H J Rozycki.   

Abstract

OBJECTIVES: To determine if tracheal lavage concentrations of the transcription factor NF-kappaB, which is activated by risk factors associated with bronchopulmonary dysplasia (BPD) and induces expression of cytokines associated with BPD, is related to BPD in premature infants.
DESIGN: Serial tracheal lavage samples from intubated premature infants were analysed for cell count and concentrations of interleukin (IL)8 and NF-kappaB, corrected for dilution by secretory component concentrations.
SETTING: Level III university hospital neonatal intensive care unit. PATIENTS: Thirty three intubated infants (mean (SD) birth weight 903 (258) g, median gestation 27 weeks (range 24-31)) in the first 14 days of life. MAIN OUTCOME MEASURES: Tracheal effluent NF-kappaB, IL8, and cell counts, corrected for dilution by secretory component measurement.
RESULTS: Square root transformed NF-kappaB concentrations were significantly related to signs of inflammation (cell count, p = 0.002; IL8, p = 0.019) and to simultaneous fraction of inspired oxygen in samples from the first 3 days of life (r = 0.512, p<0.003). Of the 32 subjects with samples in the first 3 days of life, the half who either died or had BPD had higher NF-kappaB concentrations than those without BPD (square root concentration 0.097 (0.043) v 0.062 (0.036) microg/microg protein/microg secretory component, p = 0.018).
CONCLUSIONS: Tracheobronchial lavage NF-kappaB concentrations are related to lung inflammation, oxygen exposure, and pulmonary outcome in intubated preterm infants. NF-kappaB activation may be an early critical step leading to BPD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16049063      PMCID: PMC2672648          DOI: 10.1136/adc.2003.045807

Source DB:  PubMed          Journal:  Arch Dis Child Fetal Neonatal Ed        ISSN: 1359-2998            Impact factor:   5.747


  26 in total

Review 1.  NFkappaB-dependent signaling pathways.

Authors:  Xiaoxia Li; George R Stark
Journal:  Exp Hematol       Date:  2002-04       Impact factor: 3.084

2.  Shear stress and endothelial cell activation.

Authors:  Aron B Fisher; Abu B Al-Mehdi; Yefim Manevich
Journal:  Crit Care Med       Date:  2002-05       Impact factor: 7.598

Review 3.  New insights into the pathogenesis of pulmonary inflammation in preterm infants.

Authors:  C P Speer
Journal:  Biol Neonate       Date:  2001

Review 4.  Transcriptional mechanisms of acute lung injury.

Authors:  J Fan; R D Ye; A B Malik
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-11       Impact factor: 5.464

5.  Ventilation-induced chemokine and cytokine release is associated with activation of nuclear factor-kappaB and is blocked by steroids.

Authors:  H D Held; S Boettcher; L Hamann; S Uhlig
Journal:  Am J Respir Crit Care Med       Date:  2001-03       Impact factor: 21.405

6.  Mesenchymal expression of nuclear factor-kappaB inhibits epithelial growth and branching in the embryonic chick lung.

Authors:  R S Muraoka; P B Bushdid; D M Brantley; F E Yull; L D Kerr
Journal:  Dev Biol       Date:  2000-09-15       Impact factor: 3.582

Review 7.  The NF-kappa B activation pathway: a paradigm in information transfer from membrane to nucleus.

Authors:  D M Rothwarf; M Karin
Journal:  Sci STKE       Date:  1999-10-26

Review 8.  Oxygen regulation of gene expression: a study in opposites.

Authors:  C T D'Angio; J N Finkelstein
Journal:  Mol Genet Metab       Date:  2000 Sep-Oct       Impact factor: 4.797

9.  Increased expression of nuclear factor-kappaB in bronchial biopsies from smokers and patients with COPD.

Authors:  A Di Stefano; G Caramori; T Oates; A Capelli; M Lusuardi; I Gnemmi; F Ioli; K F Chung; C F Donner; P J Barnes; I M Adcock
Journal:  Eur Respir J       Date:  2002-09       Impact factor: 16.671

Review 10.  NF-kappaB regulation in the immune system.

Authors:  Qiutang Li; Inder M Verma
Journal:  Nat Rev Immunol       Date:  2002-10       Impact factor: 53.106

View more
  16 in total

1.  Fatty acid-binding proteins and peribronchial angiogenesis in bronchopulmonary dysplasia.

Authors:  Elisa Ghelfi; Cagatay Karaaslan; Sara Berkelhamer; Serra Akar; Harry Kozakewich; Sule Cataltepe
Journal:  Am J Respir Cell Mol Biol       Date:  2010-12-22       Impact factor: 6.914

Review 2.  Inflammatory mediators in the immunobiology of bronchopulmonary dysplasia.

Authors:  Rita M Ryan; Qadeer Ahmed; Satyan Lakshminrusimha
Journal:  Clin Rev Allergy Immunol       Date:  2008-04       Impact factor: 8.667

3.  Hyperoxia-induced NF-kappaB activation occurs via a maturationally sensitive atypical pathway.

Authors:  Clyde J Wright; Tiangang Zhuang; Ping La; Guang Yang; Phyllis A Dennery
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-12-12       Impact factor: 5.464

Review 4.  Targeting inflammation to prevent bronchopulmonary dysplasia: can new insights be translated into therapies?

Authors:  Clyde J Wright; Haresh Kirpalani
Journal:  Pediatrics       Date:  2011-06-06       Impact factor: 7.124

5.  Yap/Taz regulate alveolar regeneration and resolution of lung inflammation.

Authors:  Ryan LaCanna; Daniela Liccardo; Peggy Zhang; Lauren Tragesser; Yan Wang; Tongtong Cao; Harold A Chapman; Edward E Morrisey; Hao Shen; Walter J Koch; Beata Kosmider; Marla R Wolfson; Ying Tian
Journal:  J Clin Invest       Date:  2019-04-15       Impact factor: 14.808

6.  Blood lactate levels differ significantly between surviving and nonsurviving patients within the same risk-adjusted Classification for Congenital Heart Surgery (RACHS-1) group after pediatric cardiac surgery.

Authors:  Vered Molina Hazan; Yael Gonen; Amir Vardi; Ilan Keidan; David Mishali; Marina Rubinshtein; Yusim Yakov; Gideon Paret
Journal:  Pediatr Cardiol       Date:  2010-05-22       Impact factor: 1.655

7.  NO inhibits hyperoxia-induced NF-κB activation in neonatal pulmonary microvascular endothelial cells.

Authors:  Clyde J Wright; Fadeke Agboke; Fengming Chen; Ping LA; Guang Yang; Phyllis A Dennery
Journal:  Pediatr Res       Date:  2010-12       Impact factor: 3.756

Review 8.  The role of hyperoxia in the pathogenesis of experimental BPD.

Authors:  Bradley W Buczynski; Echezona T Maduekwe; Michael A O'Reilly
Journal:  Semin Perinatol       Date:  2013-04       Impact factor: 3.300

Review 9.  Manipulation of gene expression by oxygen: a primer from bedside to bench.

Authors:  Clyde J Wright; Phyllis A Dennery
Journal:  Pediatr Res       Date:  2009-07       Impact factor: 3.756

10.  Hydrocortisone normalizes phosphodiesterase-5 activity in pulmonary artery smooth muscle cells from lambs with persistent pulmonary hypertension of the newborn.

Authors:  Marta Perez; Stephen Wedgwood; Satyan Lakshminrusimha; Kathryn N Farrow; Robin H Steinhorn
Journal:  Pulm Circ       Date:  2014-03       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.